You can't always get what you want, but if you try sometimes, you get want you need. Rolling Stones
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The fact is, a Biden win is already baked into to the market. He is ahead by double digits in most polls so it looks VERY likely he will win. The markets do not crash when an expected event occurs.
When an unexpected event occurs, like a surprise earning beat happens, the share price will soar. I am hopeful that such an event will occur after OPK reports this week. (after closing on Thursday). TGIF so all can enjoy.
The fact is, a Biden win is already baked into to the market. He is ahead by double digits in most polls so it looks VERY likely he will win. The markets do not crash when an expected event occurs.
When an unexpected event occurs, like a surprise earning beat happens, the share price will soar. I am hopeful that such an event will occur after OPK reports this week. (after closing on Thursday). TGIF so all can enjoy.
Without the pre-market run up that I expected, it appears when we get the earnings surprise, that is when the stock will pop. Although there is still some time left to get a pre earnings run up the low trading volume does not create the needed push higher.
Is anyone else expecting blowout earnings? Followed by a 5-10% jump in the share price after hours? Followed by an additional 5-10% jump the next day?
$5 is VERY possible by the end of the month!
Only 12 more trading days until 3Q earnings report. There should be a price run up as we get closer to the report. I believe the run up will start this week and we should see a bunch of 3-5% up days. This should also create a short squeeze as well. $5 is more likely than not, so let’s all enjoy the next few weeks.
The Rayaldee trial results should be out the last 2 weeks of November, anything sooner would be a surprise.
How many days with the share price going up 3-5% increase can the shorts withstand? The short squeeze is on and should continue.
With so much recent good news like the human growth hormone, Rayaldee testing going on for a COVID cure and NYC schools contract for BRL testing, the increase in the share price WILL CONTINUE. With the 3Q results coming out soon, many are looking forward to great revenue results which should REALLY make the share price pop. Profitability is so important to Biotechs and Opko should finally be profitable with all the new revenues from BRL and many more in the future. It appears there is little to no down side for Opko which should allow the share price to continue its steady rise upwards.
The rayaldee test trial was announced on Sept 15. The trial,takes 4 weeks once the subjects are found which should take 2-3 weeks. Analyzing the results maybe 2-3 weeks. Total time from start about 9 weeks, so look for results late Nov or early dec.
I feel bad for the shorts that have not sold yet
DeGen @Lauglin cow manure
I hope may several emails to Mad Money about Rayaldee convinced Cramer to have Cohen on to explain what is going on. Maybe all the others here wrote in as well to have Cramer interview Cohen, so I don’t want to take all the credit. But you guys should realize I kept pushing you to send an email or tweet and now it resulted in success.
DeGen @laughin cow manure
“Covered his short position in opko? (or like covered in cow manure like the BS he has spewed here?)
laughin@ the mad cow.
Cramer needs to address the great results of the Rayadee test results for opk to really move. If enough of those here write/tweet in to Madmoney maybe he will be made aware and mention it on TV. Or you can do nothing and hope he will find out.
As I watch opk. Share price rise, I am laughin@ those who have shorted the stock and those who post Cow manure about Opko.
Below is a News release story found today on CNBC. Why doesn’t Opko release it’s test results from the Rayaldee study the way way? The opko PR department is awful!
Eli Lilly reports a reduced rate of hospitalization for coronavirus patients using its antibody treatment
PUBLISHED WED, SEP 16 20206:46 AM EDTUPDATED AN HOUR AGO
Sam Meredith
@SMEREDITH19
The U.S. drugmaker said the experimental treatment had helped coronavirus patients rid their systems of the virus sooner, potentially preventing them from hospitalization.
The antibody, developed by Eli Lilly and AbCeller, was identified from a blood sample taken from one of the first U.S. patients who recovered from Covid-19.
Eli Lilly is one of several companies developing antibody drugs as a potential bridge to a coronavirus vaccine, alongside GlaxoSmithKline and Regeneron Pharmaceuticals.
WATCH NOW
VIDEO03:19
Eli Lilly reports results from Covid-19 phase 2 antibody drug trial
LONDON — Eli Lilly said on Wednesday its antibody-based drug had been shown to reduce the rate of hospitalization for coronavirus patients recently diagnosed with mild-to-moderate symptoms of Covid-19.
The U.S. drugmaker said it tested three different doses of LY-CoV555 against a placebo in a trial enrolling roughly 450 patients. The middle dose of 2,800 mg met the trial’s target of significantly reducing the presence of SARS-CoV-2 after 11 days.
Other doses of the antibody-drug, including the 700 mg dose and the 7,000 mg dose, did not meet that goal.
The announcement comes at a time when many are closely-monitoring the development of antibody drugs as a potential bridge to a coronavirus vaccine.
To date, more than 29.5 million people have contracted Covid-19 worldwide, with 935,591 related deaths, according to data compiled by Johns Hopkins University.
“These interim data from the BLAZE-1 trial suggest that LY-CoV555, an antibody specifically directed against SARS-CoV-2, has a direct antiviral effect and may reduce COVID-related hospitalizations,” Daniel Skovronsky, Lilly’s chief scientific officer and president of Lilly Research Laboratories, said in a statement.
“The results reinforce our conviction that neutralizing antibodies can help in the fight against COVID-19,” Skovronsky said.
Shares of Eli Lilly rose around 2.6% in pre-market trade shortly after the announcement.
LY-CoV555 belongs to a class of treatments known as monoclonal antibodies. It is designed to block viral attachment and entry into human cells, thus neutralizing the virus and potentially preventing and treating the coronavirus.
The antibody, developed by Eli Lilly and AbCeller, was identified from a blood sample taken from one of the first U.S. patients who recovered from Covid-19.
Eli Lilly is one of several companies developing antibody drugs, alongside GlaxoSmithKline and Regeneron Pharmaceuticals.
I need my $3.50 calls to get in the money by Friday! Go Opko
The test trials that resulted in a huge success for Rayaldee will soon be a huge CASH input to Opko coffers. A one Month Rx (30 day supply) costs over $1,000, yes over one thousand dollars. Imagine how much cash that will bring if Rayaldee is prescribed to the thousands of Covid patients.
The news of the test trial results needs to spread so EVERY doctor in The world prescribes Rayaldee to Covid or possible Covid patients. I would assume the government would pay all or most of the cost of the drug. What better payor then the government for Opko’s pill.
Let’s continue telling the news media about this test trial until everyone knows about these great results, not just those here.
DeGen
Rah Rah Sis Boom Ba
Go Opko Go
??????????
It’s nice to see one stock (opko) up 5% today in a market that was down down down. Plus up another 2% after hours. There must be something really good about opko to buck the market trend like this. Could it be the test results of the Rayaldee test trial that were so successful and still not on national news or television. Can’t wait for the cat to get out of the bag. $4-$5 for sure.
DeGen
Ps: How, I only gamble when the odds are in my favor. Like picking the right group to be in after the results are in.
Another idea!
Why not tweet, email, text, President Trump about the test results. He is a big fan of medicine that will help prevent the Covid.
Has anyone else here gotten off there ass and done something to spread this news. It can only help the share price when the good news about the test results reaches the public. Do you want to help can the share price moving up? Well DO SOMETHING!!!
The news about the Rayadee test trials is spreading a slower than I thought it would. Once the main stream media picks up on these favorable test trial results it will be reflected in the share price going up to $4 to $5. Just give it time as there is no denying how good the test results were. Everyone should text/email Cramer about this test. The more that do that, the more likely he will watch the English Dr’s video and talk about it on TV. Please send your text/email today!
Agreed a gap up Monday AM. Watch pre marker trading, it should heavy.
For those who aren’t on Vit D and get Covid, they would need Rayaldee to get a quick fix of whatever VIt D takes days to produce in your body. That should be a huge market as soon as the news about Rayadee curing affect continues to spread around the medical community. There is no way to hold the share Price down with this kind of news.
Howard, maybe you should listen to Dr. Campbell’s video. He choose the group that took the Calcifediol as he was convinced the drug helped in curing sick Covid patients. Maybe you should rethink your position in denying the Calcifediol actually helps. Do you still want to be in the group where the deaths occurred. Not me, in fact, you will be the only that chooses not to take Calcifediol. And yes, I will be rich(er) from my Opko shares and dance on your grave.
Howard, maybe you didn’t read (comprehend) the Calcifediol test results. ONLY one of 50 patients treated with Calcifediol required admission to the ICU, while 50% of the untreated patients required admission to the ICU.
I guess you would choose to be admitted to the ICU and possibly die. I base this on your comment that this cure is hogwash as you indicate. I will take my chances choosing to be one of the 49 out of 50 patients who take the Calcifediol. I will very likely be dancIng on your grave celebrating the money I made from OPK.
DeGen
i too added under $3
The cure for Covid using Rayadee is going to be BIG.
As this info becomes known widespread, the shareprice will rocket!
Be patient, our time is coming soon
DeGen
After reading about the Calcifediol trial results, I got very excited and bought more shares. I was was expecting to see these great results be reported on all the networks. It appears not even CNBC has reported on this. VERY DISAPPOINTING to say the least. I think if most of us text CNBC about these results they may report the story. Let’s all get off our butts and make CNBC give OPKO some news exposure.
Back in at $4.58
Yes Rig, Dr Cohen did an excellent job in explaining what happened and how the error was resolved. Kudos to him and his staff. Then the testing numbers and possible future customers led one to believe the future for Bioreference Lab is bright. Share price should react positively.
It appears you are assuming the Cramer appearance will be positive news. I am not sure that will be the case if Cohen is grilled about the screwups concerning the “false” positives from the NFL testing. This could make Opko look really bad and create more selling. Cramer is a straight shooter and will want to know what happened and most of all why it happened.
I agree, OPK will be carried by testing thru Q3, and has great potential with Rayaldee, 4KScore, and growth hormone. I will get back at some time in the future, but now I think the Salvia test will drag the share price down over the next few weeks/months.
When these partnership contracts expire (the contracts are only 2-3 months long) it is VERY LIKELY they will NOT be renewed as the competition is so much cheaper and so much faster. Would you pay more for a slower, more expensive test? I certainly would not and neither will the NBA , MLB, MLS or any other sport that is really hurting for revenues. The writing is on the wall for Bioreference testing future.
Copied from the SRNE board:
My favorite quote “ Labs are going to be eliminated from the equation.” Bye bye Covid testing for Bioreference Lab. DeGen
Bull & Bear Trading
1) The Yale test is by no means "Free." The lab costs associated with the Yale test will NOT be only $10. Overnight shipping costs to the lab will alone cost $25, maybe $40. Those who know the diagnostics industry understand that you can't get in the door for less than $80, and probably more for Covid testing. So let's dismiss the notion that anything will be free, we should all know better than this.
2) Sorrento CEO Henry Ji has stated that the SRNE-Columbia test might cost only $10. The SRNE test is an on site test that does not require a lab. The SRNE test is much cheaper than the Yale test because there are no shipping and/or lab costs for the SRNE test, but these costs are required for Yale test. ADVANTAGE ON COST GOES TO SORRENTO.
3) The testing space is evolving rapidly. Saliva is the new medium for testing. However, sending anything off to a lab is becoming a deal-breaker because the time delay makes the test almost useless. Labs are going to be removed from the equation. On-site initial testing and confirmation is the new gold standard. SRNE meets this qualification. Yale does not. ADVANTAGE OF NO LAB TESTING REQUIRED GOES TO SORRENTO.
4) The term "rapid testing" is now also evolving. Rapid testing will very soon refer to receiving test results within minutes. Rapid testing will not mean hours, and certainly not days. SRNE's test is only 30-minutes. The Yale test has to be sent off to a lab. Even if the Yale test can be completed in hours, unless somebody has access to a lab, then they must deliver the test to a lab. This time delay is unacceptable. Even if somebody has access to a testing lab, the Yale test will take hours vs SRNE's 30-minute test. Columbia has indicated that the testing time could be as little as 15-minutes if very simple items like pre-heating the bath solution is completed ahead of time. ADVANTAGE OF RAPID TESTING SPEED GOES TO SORRENTO.
5) Sorrento's test is the highest level of both sensitivity and specificity measuring 97% and 100% respectively. Yale's testing capabilities may be much lower. It should be a concern that the Yale researchers have not been forthcoming with their numbers on specificity and sensitivity. Yale has been marketing their test as cheap. Americans want affordable, but highly accurate. The entire world demands that an important Covid test be affordable and highly accurate, not just cheap. In stark contrast, the SRNE-Columbia researchers have clearly stated that 97% sensitivity and 100% specificity are the capabilities of their rapid, saliva-based test. ADVANTAGE OF TESTING ACCURACY GOES TO SORRENTO.
Clearly, Sorrento's COVI-TRACE is going to be the gold standard for the literally billions of essential Covid tests that can take place. Only the Sorrento-Columbia COVI-TRACE checks all the boxes here for rapid testing, affordable testing, highly accurate testing, and saliva-based testing. Without any ambiguity, the Sorrento-Columbia COVI-TRACE product is acknowledged as the "BEST IN CLASS" Covid test.
The FDA is desperate for COVI-TRACE to be given an EUA so that the national nightmare of overwhelmed testing labs can be alleviated. We are days away from the start of flu season, the nation is struggling to reopen local economies, schools and colleges are wanting to reopen, and even sports leagues want to play ball. The nation is desperate for the gold standard in Covid testing, COVI-TRACE is that gold standard product.
It appears the latest research from many other testing companies results in a saliva test that can be administered at home and is inexpensive. This is in DIRECT competition to OPKO's lab's test.
The writing is on the wall with regards to future income from testing revenues. I bought OPKO on its testing lab and now have sold because of the above information. You guys can can continue to be rah rah, but the future is bleak.
DeGen
HD, aren’t there 2 other testing companies that already have such a test.
Sorrento Therapeutics? CODX?
Why would someone “wait” for Opko’s test when there is already one or more on the market?
It is likely new contracts will be signed by these companies not Opko. What do you think?
DeGen
HD, I believe you are on to something BIG with regards to how testing will be conducted in the future. Another quick test company mentioned on Mad Money was Sorrento Therpeutics which also has a saliva test done at home (including results). Between SRNE and CODX, the lab test business for COVID that opko uses will go the way of the horse and buggy. Because of this my investment is OPK is now very little. Pigs get stuck!
DeGen
Ps:I will not be posting very often about opko, as I believe the run will be over soon as these other products come to market and the public is made more aware of them.
Pss: These fast and at home test kits is what the country REALLY needed to help eliminate this virus. Although this hurts my financial investment in opko, I am very grateful for this kind of innovation in testing.
Two weeks ago the SP was ~$4. A month ago the the SP was ~$2.50. Now the SP falls to $5.15 from near $6 and everyone is disappointed. I for one am elated with over 100% gain with a great possibility of going much higher from here. Is it possible the SP falls further- not likely. Is it likely that the SP will go higher. VERY LIKELY. So let’s sit back a watch the SP price climb and not worry about the inevitable fall backs that occur whenever a stock rises so fast like we have just experienced. The fact the recent CC had so much good news there is no doubt in my mind that the SP trend will only go higher and higher.
DeGen
It make sense that any testing company will make money during the pandemic.
HD everyone will be watching the share price tomorrow AM, But like all your previous doomsday predictions, you will be wrong again as usual. IMO, your negative comments indicate you are a short and hope the price goes down. All those like you that shorted this stock this year are in a world of hurt and no matter how much they say OPK will be going down, they will just have to eat their words.
The weak hands that sold after hours between $5.20 - $5.55 we regret it next week for sure.
As institutional investors read this PR over the next week or so they will likely consider investing in OPK. This may take time but Opko now checks all of the boxes
*Over $5 (no longer a penny stock)
*Profitable (. $0.05 last Q)
*Lots of potential growth with
*Rayadine
*Growth hormone
*4kscore cancer test (now approved) and being recognized/recommended by more and more doctors
*But most of all the growth in the testing Lab and all the new contracts being signed. Great exposure now during the Covid, plus for the future after Covid is no longer so dominant in the testing.
We may pick up a few more analysts that will likely come in with a buy or strong buy rating.
Is there any down side (besides the negativity of the shorts)
$10 by end of year should be a sure thing.
DeGen